
Mepra 40mg Injection
Marketer
Catholicon Pharmaceuticals Pvt Ltd
Salt Composition
Esomeprazole (40mg)
Overview Mepra 40mg Injection
Acid production in the stomach is diminished by the intravenous administration of 40mg Mepra Injection. This proton pump inhibitor (PPI) treats stomach and intestinal disorders stemming from excess acid, including acid reflux and other related conditions. It's also prophylactically used for stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Administered intravenously by a medical professional, it's reserved for patients where injection is deemed preferable to oral medication by their physician. Dosage and treatment length are individualized based on patient response and underlying health. Lifestyle modifications, such as smaller, more frequent meals and avoidance of caffeine, spicy foods, and fatty foods, can enhance treatment effectiveness. Common, typically mild, side effects include injection site reactions, nausea, headache, dizziness, gas, diarrhea, abdominal pain, and fundic gland polyps. Persistent or bothersome side effects warrant medical consultation. To mitigate potential bone loss (osteoporosis), your doctor may recommend calcium and vitamin D supplementation. Prior to receiving Mepra 40mg Injection, disclose any severe liver disease, HIV medication use, prior allergic reactions to similar medications, or existing osteoporosis. Pregnant or breastfeeding individuals should also consult their physician. Alcohol consumption should be avoided due to its potential to exacerbate symptoms by stimulating excess stomach acid.
Primary Ingredients of Mepra 40mg Injection
No text provided to rephrase.
Uses of Mepra 40mg Injection
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Mepra 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mepra 40mg Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Mepra 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mepra 40mg Injection works:
Axipra 40mg Injection, a proton pump inhibitor, decreases stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while using Mepra 40mg Injection. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Mepra 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Mepra 40mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Mepra 40mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Mepra 40mg Injection requires careful consideration in individuals exhibiting severe renal impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration is unnecessary for patients with mild or moderate kidney dysfunction.
LiverCAUTION
Administering Mepra 40mg Injection requires careful consideration in individuals exhibiting severe hepatic impairment; dosage modification may be necessary. Consult your physician for guidance. Dosage alteration is unnecessary for patients with mild or moderate liver dysfunction.
What if you forget to take Mepra 40mg Injection :
Omitting a scheduled Mepra 40mg Injection requires immediate physician consultation.
Facts to Know About Mepra 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | PPIs |
